Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of SGLT2 Inhibitor on Markers of Inflammation, Atherosclerosis and Left Ventricular Strain in Diabetic Patients With Coronary Artery Disease

NCT03398577 is registered in ClinicalTrials.gov with Sheba Medical Center as lead sponsor.

NCT NCT03398577
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03398577 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of SGLT2 Inhibitor on Markers of Inflammation, Atherosclerosis and Left Ventricular Strain in Diabetic Patients With Coronary Artery Disease
Lead sponsor
Sheba Medical Center
Phase
Phase 4
Overall status
Unknown status
Start date
February 1, 2018
Completion date
December 31, 2018
Enrollment
61 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary disease with diabetes mellitus